New Ray Medicine International Holding Overview

  • Founded
  • 2001

Founded
  • Status
  • Public

  • Employees
  • 26

Employees
  • Stock Symbol
  • 06108

Stock Symbol
  • Investments
  • 1

  • Share Price
  • $0.01

  • (As of Tuesday Closing)

New Ray Medicine International Holding General Information

Description

New Ray Medicine International Holding Ltd is engaged in the trading of pharmaceutical products in the People's Republic of China. The company's segments include Distribution and trading of pharmaceutical products and Provision of marketing and promotion services. Distribution and trading of pharmaceutical products consist of Injection drugs, Capsules and Granule drugs, Tablet drugs and Other Drugs. It generates a majority of its revenue from the distribution of Injection Drugs.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Holding Companies
Other Industries
Pharmaceuticals
Stock Exchange
HKG
Primary Office
  • Room 517, 5th Floor, Town Health Technology Centre
  • 10-12 Yuen Shun Circuit, Siu Lek Yuen, Shatin, New Territories
  • Hong Kong
  • Hong Kong
+852 2210 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

New Ray Medicine International Holding Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $0.01 - $0.35 $19.3M 1.67B 15.2M

New Ray Medicine International Holding Financials Summary

In Thousands,
USD
TTM 30-Jun-2022 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV 33,529 82,490 78,895 79,831
Revenue 23,086 43,147 17,173 15,140
EBITDA (3,551) 155 (8,473) (5,148)
Net Income (3,246) (363) (8,989) (5,629)
Total Assets 80,834 84,899 83,861 87,167
Total Debt 201 1,646 309 280
Public Fundamental Data provided by Morningstar, Inc. disclaimer

New Ray Medicine International Holding Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore New Ray Medicine International Holding‘s full profile, request access.

Request a free trial

New Ray Medicine International Holding Patents

New Ray Medicine International Holding Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
FR-2604423-A1 Storage or left-luggage (depositing) module for sailboards or the like Pending 30-Sep-1986 000000000

New Ray Medicine International Holding Executive Team (4)

Name Title Board Seat Contact Info
Linxing He Director of Subsidiaries of the Company
Lee Yuet Executive Director
Yang Fang Executive Director
You’re viewing 3 of 4 executive team members. Get the full list »

New Ray Medicine International Holding Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

New Ray Medicine International Holding Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore New Ray Medicine International Holding‘s full profile, request access.

Request a free trial

New Ray Medicine International Holding Investments (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 000000 0 10-Apr-2017 000000000 000.00 Asset Management
To view New Ray Medicine International Holding’s complete investments history, request access »